Loss of anergic B cells in prediabetic and new-onset type 1 diabetic patients

Diabetes

Volumn 64, Issue 5, 2015, Pages 1703-1712

  Smith, Mia J ^a,b   Packard, Thomas A ^a   O'neill, Shannon K ^a   Dunand, Carole J Henry ^c   Huang, Min ^c   Fitzgerald Miller, Lisa ^a   Stowell, Daniel ^a   Hinman, Rochelle M ^a   Wilson, Patrick C ^c   Gottlieb, Peter A ^a   Cambier, John C ^a  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^b Department of Environmental and Radiological Health Sciences   (United States)

^c UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN D; IMMUNOGLOBULIN M; LYMPHOCYTE ANTIGEN RECEPTOR; AUTOANTIGEN; IMMUNOGLOBULIN; LEUKOCYTE ANTIGEN;

ARTICLE; AUTOIMMUNITY; B LYMPHOCYTE; CLONAL ANERGY; COMPLEMENTARITY DETERMINING REGION; CONTROLLED STUDY; DIABETIC PATIENT; FEMALE; HUMAN; HUMAN CELL; IMPAIRED GLUCOSE TOLERANCE; INSULIN BINDING; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION REGULATION; GENETICS; IMMUNOLOGY; METABOLISM; MOLECULAR CLONING; PHYSIOLOGY;

ANTIGENS, CD; AUTOANTIGENS; B-LYMPHOCYTES; CLONAL ANERGY; CLONING, MOLECULAR; DIABETES MELLITUS, TYPE 1; ENZYME-LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION REGULATION; HUMANS; IMMUNOGLOBULINS; PREDIABETIC STATE;

EID: 84964693888     PISSN: 00121797     EISSN: 1939327X     Source Type: Journal    
DOI: 10.2337/db13-1798     Document Type: Article

References (39)

1. Pescovitz MD, Greenbaum CJ, Krause-Steinrauf H, et al.; Type 1 Diabetes TrialNet Anti-CD20 Study Group. Rituximab, B-lymphocyte depletion, and preservation of beta-cell function. N Engl J Med 2009;361:2143-2152.
2. Hulbert C, Riseili B, Rojas M, Thomas JW. B cell specificity contributes to the outcome of diabetes in nonobese diabetic mice. J Immunol 2001;167:5535- 5538.
3. Wong FS, Wen L, Tang M, et al. Investigation of the role of B-cells in type 1 diabetes in the NOD mouse. Diabetes 2004;53:2581-2587.
4. Serreze DV, Fleming SA, Chapman HD, Richard SD, Leiter EH, Tisch RM. B lymphocytes are critical antigen-presenting cells for the initiation of T cellmediated autoimmune diabetes in nonobese diabetic mice. J Immunol 1998;161: 3912-3918.
5. Goodnow CC, Crosbie J, Adelstein S, et al. Altered immunoglobulin expression and functional silencing of self-reactive B lymphocytes in transgenic mice. Nature 1988;334:676-682.
6. Gauld SB, Merrell KT, Cambier JC. Silencing of autoreactive B cells by anergy: A fresh perspective. Curr Opin Immunol 2006;18:292-297.
7. Duty JA, Szodoray P, Zheng NY, et al. Functional anergy in a subpopulation of naive B cells from healthy humans that express autoreactive immunoglobulin receptors. J Exp Med 2009;206:139-151.
8. Quách TD, Manjarrez-Orduño N, Adlowitz DG, et al. Anergic responses characterize a large fraction of human autoreactive naive B cells expressing low levels of surface IgM. J Immunol 2011;186:4640-4648.
9. Smith K, Garman L, Wrammert J, et al. Rapid generation of fully human monoclonal antibodies specific to a vaccinating antigen. Nat Protoc 2009;4:372- 384.
10. Pape KA, Taylor JJ, Maul RW, Gearhart PJ, Jenkins MK. Different B cell populations mediate early and late memory during an endogenous immune response. Science 2011;331:1203-1207.
11. Walrand S, Guillet C, Gachon P, et al. Insulin regulates protein synthesis rate in leukocytes from young and elderly healthy humans. Clin Nutr 2005;24:1089-1098.
12. Wardemann H, Yurasov S, Schaefer A, Young JW, Meffre E, Nussenzweig MC. Predominant autoantibody production by early human B cell precursors. Science 2003;301:1374-1377.
13. Isnardi I, Ng YS, Menard L, et al. Complement receptor 2/CD21- human naive B cells contain mostly autoreactive unresponsive clones. Blood 2010;115: 5026-5036.
14. Batista FD, Neuberger MS. Affinity dependence of the B cell response to antigen: A threshold, a ceiling, and the importance of off-rate. Immunity 1998;8: 751-759.
15. Henry RA, Acevedo-Suárez CA, Thomas JW. Functional silencing is initiated and maintained in immature anti-insulin B cells. J Immunol 2009;182:3432-3439.
16. Goodnow CC, Crosbie J, Jorgensen H, Brink RA, Basten A. Induction of selftolerance in mature peripheral B lymphocytes. Nature 1989;342:385-391.
17. Ichiyoshi Y, Casali P. Analysis of the structural correlates for antibody polyreactivity by multiple reassortments of chimeric human immunoglobulin heavy and light chain V segments. J Exp Med 1994;180:885-895.
18. Aguilera I, Melero J, Nuñez-Roldan A, Sanchez B. Molecular structure of eight human autoreactive monoclonal antibodies. Immunology 2001;102:273-280.
19. Meffre E, Davis E, Schiff C, et al. Circulating human B cells that express surrogate light chains and edited receptors. Nat Immunol 2000;1:207-213.
20. Willcox A, Richardson SJ, Bone AJ, Foulis AK, Morgan NG. Analysis of islet inflammation in human type 1 diabetes. Clin Exp Immunol 2009;155:173-181.
21. Henry-Bonami RA, Williams JM, Rachakonda AB, Karamali M, Kendall PL, Thomas JW. B lymphocyte "original sin" in the bone marrow enhances islet autoreactivity in type 1 diabetes-prone nonobese diabetic mice. J Immunol 2013; 190:5992-6003.
22. Wei C, Anolik J, Cappione A, et al. A new population of cells lacking expression of CD27 represents a notable component of the B cell memory compartment in systemic lupus erythematosus. J Immunol 2007;178:6624-6633.
23. Fecteau JF, Côté G, Néron S. A new memory CD27-IgG+ B cell population in peripheral blood expressing VH genes with low frequency of somatic mutation. J Immunol 2006;177:3728-3736.
24. Koelsch K, Zheng NY, Zhang Q, et al. Mature B cells class switched to IgD are autoreactive in healthy individuals. J Clin Invest 2007;117:1558-1565.
25. Chervonsky AV. Influence of microbial environment on autoimmunity. Nat Immunol 2010;11:28-35.
26. Ercolini AM, Miller SD. The role of infections in autoimmune disease. Clin Exp Immunol 2009;155:1-15.
27. Münz C, Lünemann JD, Getts MT, Miller SD. Antiviral immune responses: Triggers of or triggered by autoimmunity? Nat Rev Immunol 2009;9:246-258.
28. Wardemann H, Nussenzweig MC. B-cell self- Tolerance in humans. Adv Immunol 2007;95:83-110.
29. Huang SW, Haedt LH, Rich S, Barbosa J. Prevalence of antibodies to nucleic acids in insulin-dependent diabetics and their relatives. Diabetes 1981;30:873-874.
30. Triolo G, Giardina E, Scarantino G, et al. Cross-reactivity of anti-ssDNA antibodies with heparan sulfate in patients with type I diabetes mellitus. Diabetes 1989;38:718-722.
31. Triolo TM, Armstrong TK, McFann K, et al. Additional autoimmune disease found in 33% of patients at type 1 diabetes onset. Diabetes Care 2011;34:1211- 1213.
32. Barker JM, Yu J, Yu L, et al. Autoantibody "subspecificity" in type 1 diabetes: Risk for organ-specific autoimmunity clusters in distinct groups. Diabetes Care 2005;28:850-855.
33. Thomas JW, Kendall PL, Mitchell HG. The natural autoantibody repertoire of nonobese diabetic mice is highly active. J Immunol 2002;169:6617-6624.
34. Kinnunen T, Chamberlain N, Morbach H, et al. Specific peripheral B cell tolerance defects in patients with multiple sclerosis. J Clin Invest 2013;123: 2737-2741.
35. Cho JH, Gregersen PK. Genomics and the multifactorial nature of human autoimmune disease. N Engl J Med 2011;365:1612-1623.
36. Habib T, Funk A, Rieck M, et al. Altered B cell homeostasis is associated with type I diabetes and carriers of the PTPN22 allelic variant. J Immunol 2012; 188:487-496.
37. Menard L, Saadoun D, Isnardi I, et al. The PTPN22 allele encoding an R620W variant interferes with the removal of developing autoreactive B cells in humans. J Clin Invest 2011;121:3635-3644.
38. Cambier JC. Autoimmunity risk alleles: hotspots in B cell regulatory signaling pathways. J Clin Invest 2013;123:1928-1931.
39. Knip M, Simell O. Environmental triggers of type 1 diabetes. Cold Spring Harb Perspect Med 2012;2:a007690.